BRAF-mutated colorectal adenocarcinomas: Pathological heterogeneity and clinical implications-Reference-Cited by-同舟云学术

BRAF-mutated colorectal adenocarcinomas: Pathological heterogeneity and clinical implications

Published:2022-04 Issue: Volume:172 Page:103647
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Angerilli Valentina,Sabella Giovanna,Centonze Giovanni,Lonardi Sara,Bergamo Francesca,Mangogna Alessandro,Pietrantonio Filippo,Fassan Matteo,Milione Massimo

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference127 articles.

1. Immunohistochemistry using the BRAF V600E mutation-specific monoclonal antibody VE1 is not a useful surrogate for genotyping in colorectal adenocarcinoma;Adackapara;Histopathology,2013

2. BRAF V600E mutation detection by immunohistochemistry in colorectal carcinoma;Affolter;Genes Chromosomes Cancer,2013

3. Pembrolizumab in microsatellite-instability-high advanced colorectal cancer;André;N. Engl. J. Med.,2020

4. Intratumor morphologic and transcriptomic heterogeneity in (V600E)BRAF-mutated metastatic colorectal adenocarcinomas;Angerilli;ESMO Open,2021

5. The role of the pathologist in the next-generation era of tumor molecular characterization;Angerilli;Diagnostics,2021

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy in gastrointestinal cancers: Spotlight on the pivotal role of currently available biomarkers;Principles of Immunotherapy Breast and Gastrointestinal Cancers;2025

2. Unlocking the power of precision medicine: exploring the role of biomarkers in cancer management;Future Journal of Pharmaceutical Sciences;2024-01-05

3. BRAF^V600E immunohistochemistry can reliably substitute BRAF molecular testing in the Lynch syndrome screening algorithm in colorectal cancer;Histopathology;2024-01-03

4. Ibero-American Consensus Review and Incorporation of New Biomarkers for Clinical Practice in Colorectal Cancer;Cancers;2023-09-01

5. Clinical research progress on BRAF V600E-mutant advanced colorectal cancer;Journal of Cancer Research and Clinical Oncology;2023-08-28